Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$6.69 USD
+0.14 (2.14%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $6.73 +0.04 (0.60%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.69 USD
+0.14 (2.14%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $6.73 +0.04 (0.60%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
Zacks News
Sensus Healthcare, Inc. (SRTS) Just Reclaimed the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Zacks.com featured highlights include: Metropolitan Bank Holding Corp., Horizon Bancorp Inc., CBIZ Inc., Sensus Healthcare Inc. and Ocwen Financial Corp
by Zacks Equity Research
Metropolitan Bank Holding Corp., Horizon Bancorp Inc., CBIZ Inc., Sensus Healthcare Inc. and Ocwen Financial Corp are highlighted in this Screen of the Week article.
5 Stocks With Recent Price Strength in a Volatile January
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MCB, HBNC, SRTS, OCN and CBZ.
Bet on These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Toyota Motor (TM), ACM Research (ACMR) and Vocera (VCRA) are well poised to gain.
Zacks.com featured highlights include: Photronics, Inc., MGIC Investment Corp., Sensus Healthcare, Inc. and Wipro Ltd
by Zacks Equity Research
Photronics, Inc., MGIC Investment Corp., Sensus Healthcare, Inc. and Wipro Ltd are included in this blog.
Sensus Healthcare, Inc. (SRTS) Moves 5.1% Higher: Will This Strength Last?
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Buy These 4 Breakout Stocks to Get Explosive Returns
by Nitish Marwah
PLAB, MTG, SRTS, and WIT have been selected as the breakout stocks for today.
Here's What Could Help Sensus Healthcare, Inc. (SRTS) Maintain Its Recent Price Strength
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Best Momentum Stocks to Buy for January 3rd
by Zacks Equity Research
SRTS, ANIP, and AZO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 3, 2022
Fretting Over Market Volatility? Bet on These 4 Low-Beta Stocks
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. AMN Healthcare (AMN), Vista Outdoor (VSTO), Sensus Healthcare (SRTS) and Ameresco (AMRC) are well poised to gain.
Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare
What History Shows Us About 2022 Market Returns
by Bryan Hayes
What to Expect From the Markets In 2022
Best Momentum Stocks to Buy for December 17th
by Zacks Equity Research
EXPD, FORR, BLDR, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 17, 2021.
Sail Through the Choppy Market With These 3 Low-Beta Stocks
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. Amphastar (AMPH), Sanderson Farms (SAFM) and Sensus Healthcare (SRTS) are well poised to gain.
Best Momentum Stocks to Buy for December 15th
by Zacks Equity Research
GES, AOSL, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 15, 2021.
Sensus Healthcare, Inc. (SRTS) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Sensus Healthcare, Inc. (SRTS) a Good Fit for "Trend Investing"
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Zacks.com featured highlights include: Sensus Healthcare, Dorman Products and Sociedad Quimica y Minera
by Zacks Equity Research
Zacks.com featured highlights include: Sensus Healthcare, Dorman Products and Sociedad Quimica y Minera
3 Best Stocks to Invest In for Superb Earnings Acceleration
by Tirthankar Chakraborty
Sensus Healthcare (SRTS), Dorman Products (DORM) & Sociedad Quimica y Minera (SQM) at present flaunt solid earnings acceleration. This calls for investing in them right away.
The Zacks Analyst Blog Highlights: Build-A-Bear, REX American Resources, Medallion Financial, First Community and Sensus Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Build-A-Bear, REX American Resources, Medallion Financial, First Community and Sensus Healthcare
Wall Street Analysts Believe Sensus Healthcare, Inc. (SRTS) Could Rally 27%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.8% in Sensus Healthcare, Inc. (SRTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Top 5 Small Caps Flying High Defying Omicron-Led Turmoil
by Nalak Das
We have narrowed our search to five small cap stocks that have surged since the Thanksgiving Day. These are: BBW, FCCO, REX, MFIN and SRTS.
Bet on These 3 Low-Beta Stocks to Combat Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Amphastar Pharmaceuticals (AMPH), AMN Healthcare (AMN) & Sensus Healthcare (SRTS) are well poised to gain.
Best Momentum Stocks to Buy for November 30th
by Zacks Equity Research
VSTO, SRTS, PLCE, and NMRK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 30, 2021.
Recent Price Trend in Sensus Healthcare, Inc. (SRTS) is Your Friend, Here's Why
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.